QIAGEN Gross Profit 2006-2020 | QGEN

QIAGEN annual/quarterly gross profit history and growth rate from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • QIAGEN gross profit for the quarter ending June 30, 2020 was $0.295B, a 19.95% increase year-over-year.
  • QIAGEN gross profit for the twelve months ending June 30, 2020 was $1.073B, a 8.14% increase year-over-year.
  • QIAGEN annual gross profit for 2019 was $1.005B, a 0.43% increase from 2018.
  • QIAGEN annual gross profit for 2018 was $1.001B, a 8.5% increase from 2017.
  • QIAGEN annual gross profit for 2017 was $0.923B, a 9.22% increase from 2016.
QIAGEN Annual Gross Profit
(Millions of US $)
2019 $1,005
2018 $1,001
2017 $923
2016 $845
2015 $827
2014 $865
2013 $815
2012 $824
2011 $750
2010 $716
2009 $667
2008 $600
2007 $434
2006 $325
2005 $275
QIAGEN Quarterly Gross Profit
(Millions of US $)
2020-06-30 $295
2020-03-31 $244
2019-12-31 $280
2019-09-30 $255
2019-06-30 $246
2019-03-31 $225
2018-12-31 $265
2018-09-30 $257
2018-06-30 $254
2018-03-31 $226
2017-12-31 $261
2017-09-30 $241
2017-06-30 $225
2017-03-31 $196
2016-12-31 $228
2016-09-30 $221
2016-06-30 $211
2016-03-31 $185
2015-12-31 $224
2015-09-30 $205
2015-06-30 $201
2015-03-31 $198
2014-12-31 $216
2014-09-30 $223
2014-06-30 $216
2014-03-31 $210
2013-12-31 $236
2013-09-30 $211
2013-06-30 $169
2013-03-31 $200
2012-12-31 $233
2012-09-30 $199
2012-06-30 $203
2012-03-31 $189
2011-12-31 $202
2011-09-30 $188
2011-06-30 $188
2011-03-31 $172
2010-12-31 $189
2010-09-30 $181
2010-06-30 $173
2010-03-31 $173
2009-12-31 $188
2009-09-30 $173
2009-06-30 $160
2009-03-31 $146
2008-12-31 $157
2008-09-30 $153
2008-06-30 $148
2008-03-31 $141
2007-12-31 $135
2007-09-30 $116
2007-06-30 $93
2007-03-31 $89
2006-12-31 $126
2006-09-30 $82
2006-06-30 $113
2006-03-31 $109
2005-12-31 $75
2005-09-30 $69
2005-06-30 $67
2005-03-31 $64
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.369B $1.526B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.299B 15.78
Bristol Myers Squibb (BMY) United States $134.404B 10.35
CSL (CSLLY) Australia $95.311B 0.00
Gilead Sciences (GILD) United States $81.542B 11.74
Vertex Pharmaceuticals (VRTX) United States $70.706B 39.46
Regeneron Pharmaceuticals (REGN) United States $60.112B 22.99
Biogen (BIIB) United States $43.595B 7.46
Illumina (ILMN) United States $43.511B 50.60
Seattle Genetics (SGEN) United States $30.564B 0.00
Moderna (MRNA) United States $26.789B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.014B 10.42
Genmab (GMAB) Denmark $24.574B 15.52
BeiGene (BGNE) Cayman Islands $23.647B 0.00
Genmab (GNMSF) Denmark $22.914B 5.28
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Incyte (INCY) United States $19.775B 0.00
Immunomedics (IMMU) United States $19.726B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.096B 37.66
Alnylam Pharmaceuticals (ALNY) United States $15.194B 0.00
BioNTech SE (BNTX) Germany $15.110B 0.00
Bio-Rad Laboratories (BIO.B) United States $14.252B 64.46
BioMarin Pharmaceutical (BMRN) United States $14.211B 103.11
ARGENX SE-ADR (ARGX) Netherlands $11.492B 0.00
Sarepta Therapeutics (SRPT) United States $11.307B 0.00
Exact Sciences (EXAS) United States $11.246B 0.00
Guardant Health (GH) United States $10.017B 0.00
Bio-Techne Corp (TECH) United States $9.455B 64.88
Galapagos (GLPG) Belgium $9.207B 33.36
Exelixis (EXEL) United States $8.324B 30.27
Ascendis Pharma (ASND) Denmark $7.700B 0.00
Repligen (RGEN) United States $7.650B 121.43
SWEDISH ORP BIO (BIOVF) Sweden $7.574B 18.84
Mirati Therapeutics (MRTX) United States $7.214B 0.00
Novavax (NVAX) United States $7.078B 0.00
MyoKardia (MYOK) United States $6.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.427B 0.00
Acceleron Pharma (XLRN) United States $6.243B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.229B 0.00
Adaptive Biotechnologies (ADPT) United States $6.093B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.974B 185.09
Emergent Biosolutions (EBS) United States $5.379B 21.31
Ultragenyx Pharmaceutical (RARE) United States $4.994B 0.00
Zai Lab (ZLAB) China $4.697B 0.00
MorphoSys AG (MOR) Germany $4.439B 58.17
China Biologic Products (CBPO) China $4.399B 26.11
Legend Biotech (LEGN) United States $4.359B 0.00
Blueprint Medicines (BPMC) United States $4.330B 0.00
Denali Therapeutics (DNLI) United States $4.116B 0.00
Arena Pharmaceuticals (ARNA) United States $4.069B 0.00
Vir Biotechnology (VIR) United States $4.067B 0.00
NeoGenomics (NEO) United States $3.850B 1162.00
Halozyme Therapeutics (HALO) United States $3.841B 0.00
Bluebird Bio (BLUE) United States $3.703B 0.00
Amicus Therapeutics (FOLD) United States $3.602B 0.00
Reata Pharmaceuticals (RETA) United States $3.473B 0.00
Insmed (INSM) United States $3.367B 0.00
Global Blood Therapeutics (GBT) United States $3.355B 0.00
Principia Biopharma (PRNB) United States $3.323B 0.00
Fate Therapeutics (FATE) United States $3.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.964B 0.00
Alkermes (ALKS) Ireland $2.934B 61.50
Twist Bioscience (TWST) United States $2.893B 0.00
Inovio Pharmaceuticals (INO) United States $2.625B 0.00
Sorrento Therapeutics (SRNE) United States $2.294B 0.00
PHARMA MAR SA (PHMMF) Spain $2.214B 0.00
I-Mab (IMAB) China $2.156B 0.00
Revance Therapeutics (RVNC) United States $2.117B 0.00
Mesoblast (MESO) Australia $2.111B 0.00
Intra-Cellular Therapies (ITCI) United States $2.084B 0.00
Seres Therapeutics (MCRB) United States $2.048B 0.00
Editas Medicine (EDIT) United States $2.036B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Zymeworks (ZYME) Canada $1.978B 0.00
Eidos Therapeutics (EIDX) United States $1.923B 0.00
UniQure (QURE) Netherlands $1.853B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.804B 0.00
Viela Bio (VIE) United States $1.754B 0.00
Mersana Therapeutics (MRSN) United States $1.658B 0.00
Amarin (AMRN) Ireland $1.619B 0.00
Cytokineticsorporated (CYTK) United States $1.534B 0.00
Sangamo Therapeutics (SGMO) United States $1.520B 0.00
Ligand Pharmaceuticals (LGND) United States $1.514B 51.17
Zealand Pharma (ZEAL) Denmark $1.472B 0.00
Beam Therapeutics (BEAM) United States $1.469B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.459B 0.00
Arcus Biosciences (RCUS) United States $1.440B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.439B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.399B 0.00
Coherus BioSciences (CHRS) United States $1.363B 7.95
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Epizyme (EPZM) United States $1.331B 0.00
Intellia Therapeutics (NTLA) United States $1.319B 0.00
NGM Biopharmaceuticals (NGM) United States $1.315B 0.00
Compugen (CGEN) Israel $1.243B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.143B 0.00
Alector (ALEC) United States $1.118B 0.00
Alcobra (ARCT) United States $1.110B 0.00
REGENXBIO (RGNX) United States $1.102B 0.00
Athenex (ATNX) United States $1.067B 0.00
Arvinas (ARVN) United States $1.052B 0.00
Adverum Biotechnologies (ADVM) United States $1.035B 0.00
Retrophin (RTRX) United States $1.001B 0.00
Pliant Therapeutics (PLRX) United States $0.979B 0.00
Castle Biosciences (CSTL) United States $0.956B 0.00
Agenus (AGEN) United States $0.952B 0.00
Myriad Genetics (MYGN) United States $0.937B 0.00
Heska (HSKA) United States $0.913B 0.00
NantKwest (NK) United States $0.899B 0.00
Morphic Holding (MORF) United States $0.885B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.864B 0.00
Cellectis S.A (CLLS) France $0.864B 0.00
Vericel (VCEL) United States $0.859B 0.00
Intrexon (PGEN) United States $0.843B 0.00
Frequency Therapeutics (FREQ) United States $0.835B 0.00
Protagonist Therapeutics (PTGX) United States $0.780B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
MiMedx (MDXG) United States $0.711B 0.00
Codexis (CDXS) United States $0.710B 0.00
WAVE Life Sciences (WVE) Singapore $0.696B 0.00
Cara Therapeutics (CARA) United States $0.693B 0.00
Northwest Biotherapeutics (NWBO) United States $0.691B 0.00
Clovis Oncology (CLVS) United States $0.660B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.658B 0.00
AC Immune SA (ACIU) Switzerland $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Autolus Therapeutics (AUTL) United Kingdom $0.630B 0.00
Dynavax Technologies (DVAX) United States $0.618B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Albireo Pharma (ALBO) United States $0.585B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.585B 0.00
Geron (GERN) United States $0.571B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.543B 4.75
Scholar Rock Holding (SRRK) United States $0.534B 0.00
Forte Biosciences (FBRX) United States $0.532B 0.00
IVERIC Bio (ISEE) United States $0.527B 0.00
Anika Therapeutics (ANIK) United States $0.521B 22.79
Cue Biopharma (CUE) United States $0.508B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.492B 0.00
Kala Pharmaceuticals (KALA) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
Celldex Therapeutics (CLDX) United States $0.474B 0.00
UROGEN PHARMA (URGN) United States $0.467B 0.00
Starpharma Holdings (SPHRY) Australia $0.451B 0.00
MannKind (MNKD) United States $0.442B 0.00
Avid Bioservices (CDMO) United States $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.437B 0.00
Syros Pharmaceuticals (SYRS) United States $0.436B 0.00
Pfenex (PFNX) United States $0.436B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
Prothena (PRTA) Ireland $0.415B 0.00
IBio (IBIO) United States $0.410B 0.00
BioDelivery Sciences (BDSI) United States $0.409B 28.93
Athersys (ATHX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Kamada (KMDA) Israel $0.400B 19.11
Sutro Biopharma (STRO) United States $0.398B 0.00
Fortress Biotech (FBIO) United States $0.395B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
PDL BioPharma (PDLI) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 8.67
Bicycle Therapeutics (BCYC) United Kingdom $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.361B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.347B 0.00
Merus (MRUS) Netherlands $0.338B 0.00
CytomX Therapeutics (CTMX) United States $0.332B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Innate Pharma S.A (IPHA) France $0.321B 0.00
Precision BioSciences (DTIL) United States $0.311B 0.00
Menlo Therapeutics (VYNE) United States $0.304B 0.00
Prometic Life Sciences (LMNL) Canada $0.297B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.296B 0.00
Trevena (TRVN) United States $0.292B 0.00
Selecta Biosciences (SELB) United States $0.283B 0.00
Affimed (AFMD) Germany $0.282B 0.00
ChromaDex (CDXC) United States $0.280B 0.00
Cyclerion Therapeutics (CYCN) United States $0.276B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
NextCure (NXTC) United States $0.259B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Arbutus Biopharma (ABUS) United States $0.247B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
Verastem (VSTM) United States $0.231B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.223B 0.00
XOMA (XOMA) United States $0.222B 0.00
DBV Technologies S.A (DBVT) France $0.218B 0.00
Dyadic (DYAI) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
Checkpoint Therapeutics (CKPT) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.202B 0.00
Biofrontera AG (BFRA) Germany $0.199B 0.00
Kindred Biosciences (KIN) United States $0.193B 0.00
Theratechnologies (THTX) Canada $0.191B 0.00
Cardiff Oncology (CRDF) United States $0.188B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.182B 8.50
GENFIT S.A (GNFT) France $0.180B 0.00
Exicure (XCUR) United States $0.177B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
Eton Pharmaceuticals (ETON) United States $0.170B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.163B 0.00
Aptinyx (APTX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.154B 0.00
CorMedix Inc (CRMD) United States $0.147B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Five Prime Therapeutics (FPRX) United States $0.145B 0.00
AquaBounty Technologies (AQB) United States $0.145B 0.00
Bellus Health (BLU) Canada $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Cidara Therapeutics (CDTX) United States $0.140B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.132B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Gritstone Oncology (GRTS) United States $0.126B 0.00
Strongbridge Biopharma (SBBP) United States $0.121B 0.00
Windtree Therapeutics (WINT) United States $0.120B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Vaccinex (VCNX) United States $0.119B 0.00
Palatin Technologies (PTN) United States $0.119B 3.04
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
Orgenesis (ORGS) United States $0.106B 5.38
PHASEBIO PHARMA (PHAS) United States $0.103B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Idera Pharmaceuticals (IDRA) United States $0.092B 0.00
Bionano Genomics (BNGO) United States $0.087B 0.00
Oncobiologics (OTLK) United States $0.084B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Edesa Biotech (EDSA) Canada $0.069B 0.00
AmpliPhi Biosciences (ARMP) United States $0.068B 0.00
Evogene (EVGN) Israel $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
TRACON Pharmaceuticals (TCON) United States $0.063B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Cocrystal Pharma (COCP) United States $0.054B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 76.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
Novogen (KZIA) Australia $0.050B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.049B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
IMMURON (IMRN) Australia $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
OvaScience (MLND) United States $0.031B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Acorda Therapeutics (ACOR) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.027B 0.00
Celsion (CLSN) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00